A comprehensive quality control and cost comparison study of branded and generic angiotensin receptor blockers
This study was designed to assess both the quality and cost aspects of various branded and generic formulations of angiotensin receptor blockers, specifically Irbesartan, Losartan Potassium, Olmesartan Medoxomil, Telmisartan, and Valsartan. The collected samples underwent distinct quality evaluation...
Saved in:
Main Authors: | Arvind Kumar Sharma (Author), Shruti Rastogi (Author), Faraat Ali (Author), Anuj Prakash Yadav (Author), Ramesh K. Goyal (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers
by: Jacinthe Leclerc, et al.
Published: (2020) -
Prescription Pattern and Costs of Angiotensin II Receptor Blockers in Hypertensive Outpatients
by: Nurmainah Nurmainah, et al.
Published: (2018) -
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012) -
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
by: Gábor Kriszta, et al.
Published: (2021) -
Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
by: Hany A Al-Hussaniy, et al.
Published: (2023)